The Wall Street Journal: Experimental peanut-allergy drug shows encouraging results in protecting kids

Several major car companies reported softer U.S. sales for 2019, as the auto market shows signs of easing after posting a multiyear streak of near-record results......»»

Amgen Inc on Tuesday said its second-quarter revenue fell 3% due to more competition for its older off-patent drugs, but rising sales of newer medicines helped its results exceed Wall Street forecasts......»»

Target Corp. on Tuesday reported much better than expected first-quarter results, powered by the return of many consumers to physical stores and the revival of higher-margin categories like apparel. The Wall Street Journal has an early take on the .....»»

Broadway can finally raise the curtain again......»»

Warren Buffett’s Berkshire Hathaway swung to a quarterly profit on stock-market gains and better results from its insurance business......»»

Self-driving company TuSimple Inc. unveiled paperwork for its initial public offering Tuesday showing it has lost more than $300 million over the past three years in the race to be the first to launch fully autonomous long-haul trucks......»»

Fox Business has canceled “Lou Dobbs Tonight,” one of its consistently highest-rated shows, a day after its host was named as a defendant in a $2.7 billion defamation lawsuit......»»

Consulting giant McKinsey & Co. has reached a $573 million settlement with states over its work advising OxyContin maker Purdue Pharma LP and other drug manufacturers to aggressively market opioid painkillers, according to people familiar with the matter......»»

Quibi is in advanced talks to sell its content catalog to Roku Inc., according to people familiar with the matter, as the short-form streaming service winds down its operations following an unsuccessful run......»»

Vice President Mike Pence asked a .....»»

Pandemic buying trends that favored household goods and food over apparel continued, according to early sales data from firms that track shopper spending......»»

The Food and Drug Administration is moving at “lightning speed” to review data on Gilead Sciences Inc.’s experimental Covid-19 treatment remdesivir, Commissioner Stephen Hahn said, after encouraging results emerged from a key U.S. trial......»»

The Food and Drug Administration is moving at “lightning speed” to review data on Gilead Sciences Inc.’s experimental Covid-19 treatment remdesivir, Commissioner Stephen Hahn said, after encouraging results emerged from a key U.S. trial......»»

Asian equity markets were poised to gain on Thursday, tracking Wall Street's rally after positive trial results of an experimental COVID-19 treatment, a U.S. Federal Reserve pledge to shore up the economy and a jump in oil prices......»»

U.S. stocks jumped to seven-week highs on Wednesday as Gilead Sciences gave an encouraging update on a potential COVID-19 treatment and upbeat earnings from Google-parent Alphabet boosted the so-called market-leading FAANG stocks......»»

U.S. stocks jumped to seven-week highs on Wednesday as Gilead Sciences gave an encouraging update on a potential COVID-19 treatment and upbeat earnings from Google-parent Alphabet boosted shares of other technology and internet giants......»»

U.S. stocks opened higher on Wednesday after Gilead Sciences gave an encouraging update on a potential COVID-19 treatment, while upbeat earnings reports from Boeing and Google-parent Alphabet added to the sentiment......»»

Wall Street was in positive territory on Tuesday but surrendered strong earlier gains after a report that an experimental antiviral drug for the coronavirus flopped in its first randomized clinical trial......»»

Wall Street's main indexes pared gains sharply on Thursday, after a report that Gilead Sciences experimental coronavirus drug flopped in its first randomized clinical trial......»»

Americans are worried about lifting stay-at-home orders too quickly amid the coronavirus pandemic, which has dramatically upended life in a month marked by business shutdowns, job losses and illness, according to a new Wall Street Journal/NBC News poll......»»